Cargando…
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Autores principales: | Liu, Jia, Cao, Ruiyuan, Xu, Mingyue, Wang, Xi, Zhang, Huanyu, Hu, Hengrui, Li, Yufeng, Hu, Zhihong, Zhong, Wu, Wang, Manli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078228/ https://www.ncbi.nlm.nih.gov/pubmed/32194981 http://dx.doi.org/10.1038/s41421-020-0156-0 |
Ejemplares similares
-
The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro
por: Wang, Xi, et al.
Publicado: (2020) -
Infection of human sweat glands by SARS-CoV-2
por: Liu, Jia, et al.
Publicado: (2020) -
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
por: Wang, Manli, et al.
Publicado: (2020) -
Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020) -
Antiviral effects and tissue exposure of tetrandrine against SARS‐CoV‐2 infection and COVID‐19
por: Liu, Jia, et al.
Publicado: (2023)